BUSINESS BRIEFING / HEALTHCARE
Times Wire Reports
A federal appeals court sided with Johnson & Johnson in a long-running patent dispute with rival Boston Scientific Corp. over technology used in artery-opening stents.
The Court of Appeals for the Federal Circuit reversed a 2005 decision against J&J; by a lower court that found that the New Brunswick, N.J., company’s Cypher stent violated a patent held by Boston Scientific, of Natick, Mass. Boston Scientific said it was considering challenging the decision.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
